Publication Date:
2013-07-25
Description:
Key Points Erwinia asparaginase was granted FDA approval in November 2011 for use in patients with allergic reactions to E coli-derived asparaginase. Erwinia asparaginase 25 000-IU/m2 for 6 intramuscular doses M/W/F can be substituted for a single dose of pegaspargase.
Print ISSN:
0006-4971
Electronic ISSN:
1528-0020
Topics:
Biology
,
Medicine
Permalink